Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Cellular and molecular control of lipid metabolism in idiopathic pulmonary fibrosis: clinical application of the lysophosphatidic acid pathway
Milk exosome-liposome hybrid vesicles with self-adapting surface properties overcome the sequential absorption barriers for oral delivery of peptides
Combination needs to be started early - CKD 3a - i.e in primary care - by the time they are in my clinic CKD G4+ - can't reverse the loss but only stabilise and slow down progression #MedTwitter #CardioTwitter #Nephpearls Its very exciting
In addition, the FY2012 NDAA requires that industry fully report its SBIR Phase III investments
US$ 29.78
US$ 20.56
US$ 20.97
US$ 24.81
US$ 29.09
US$ 25.91
US$ 21.06
US$ 27.94
US$ 27.15
US$ 23.47
US$ 25.31
US$ 20.34
US$ 20.93
US$ 27.59
US$ 22.28
US$ 25.54
